RecruitingNot Applicable

Efficacy and Safety of a New Sperm Capacitation Method

Spain300 participantsStarted 2025-01-14

Plain-language summary

Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to evaluate the efficacy and safety of HyperSperm, a new sperm capacitation method, in 300 semen samples with various characteristics and abnormalities, in an in vitro study over 12 months.

Who can participate

Age range18 Years – 60 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Ability to provide a semen sample via masturbation Exclusion Criteria: * Current diagnosis of a sexually transmitted infection (STI) * Previous diagnosis of hepatitis A, B, C, D, or HIV * Prior participation in this study * Participation in a clinical trial involving an intervention within the last 3 months

What they're measuring

Hyperactivation

Timeframe: 2 hours

Trial details

NCT IDNCT06742437

SponsorFecundis Lab SL

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-06

Contact for this trial

Matias Gomez Elias, PhD

+34624174355 mgomezelias@fecundis.com

View on ClinicalTrials.gov More Reproductive Issues trials